The role of immunosuppression in recurrence of hepatitis C

被引：93

作者：

Lake, JR ^{[1
]}

机构：

[1] Univ Minnesota, Div Gastroenterol, Minneapolis, MN 55455 USA

来源：

LIVER TRANSPLANTATION | 2003年 / 9卷 / 11期

关键词：

D O I：

10.1053/jlts.2003.50264

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1. Recurrent hepatitis C is an increasing problem post-transplantation. 2. It is difficult to determine histologically if alloimmunity, i.e., rejection, is also plays a role in posttransplantation hepatitis C. 3. Change in the degree of immunosuppression, rather than the absolute amount of immunosuppression, is bad for HCV-infected recipients. 4. Corticosteroid boluses are bad for HCV-infected recipients.

引用

页码：S63 / S66

页数：4

共 20 条

[1] HCV-related fibrosis progression following liver transplantation:: increase in recent years [J].

Berenguer, M ;

Ferrell, L ;

Watson, J ;

Prieto, M ;

Kim, M ;

Rayón, M ;

Córdoba, J ;

Herola, A ;

Ascher, N ;

Mir, J ;

Berenguer, J ;

Wright, TL .

JOURNAL OF HEPATOLOGY, 2000, 32 (04) :673-684

[2] Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation [J].

Brillanti, S ;

Vivarelli, M ;

De Ruvo, N ;

Aden, AA ;

Camaggi, V ;

D'Errico, A ;

Furlini, G ;

Bellusci, R ;

Roda, E ;

Cavallari, A .

LIVER TRANSPLANTATION, 2002, 8 (10) :884-888

[3] Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients [J].

Calmus, Y ;

Scheele, JR ;

Gonzalez-Pinto, I ;

Jaurrieta, EJ ;

Klar, E ;

Pageaux, GP ;

Scudamore, CH ;

Cuervas-Mons, V ;

Metselaar, HJ ;

Prestele, H ;

Girault, D .

LIVER TRANSPLANTATION, 2002, 8 (02) :123-131

[4]

Charlton M, 1999, LIVER TRANSPLANT SUR, V5, pS107

[5] Steroid-free liver transplantation using rabbit antithymocyte globulin induction: Results of a prospective randomized trial [J].

Eason, JD ;

Loss, GE ;

Blazek, J ;

Nair, S ;

Mason, AL .

LIVER TRANSPLANTATION, 2001, 7 (08) :693-697

[6]

FASOLA CG, 2002, LIVER TRANSPLANT, V8, pCA52

[7] Lack of antiviral effect of a short course of mycophenolate mofetil in patients with chronic hepatitis C virus infection [J].

Firpi, RJ ;

Nelson, DR ;

Davis, GL .

LIVER TRANSPLANTATION, 2003, 9 (01) :57-61

[8] A longitudinal analysis of hepatitis C virus replication following liver transplantation [J].

Gane, EJ ;

Naoumov, NV ;

Qian, KP ;

Mondelli, MU ;

Maertens, G ;

Portmann, BC ;

Lau, JYN ;

Williams, R .

GASTROENTEROLOGY, 1996, 110 (01) :167-177

[9] A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C [J].

Jain, A ;

Kashyap, R ;

Demetris, AJ ;

Eghstesad, B ;

Pokharna, R ;

Fung, JJ .

LIVER TRANSPLANTATION, 2002, 8 (01) :40-46

[10] Mycophenolate mofetil in combination with tacrolimus versus neoral after liver transplantation [J].

Klupp, J ;

Glanemann, M ;

Bechstein, WO ;

Platz, KP ;

Langrehr, JM ;

Keck, H ;

Settmacher, U ;

Radtke, C ;

Neuhaus, R ;

Neuhaus, P .

TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) :1113-1114

← 1 2 →